European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Endometrial cancer: asymptomatic endometrial findings. Characteristics of postmenopausal endometrial cancer
Endometrial cancer affects patients at every ages, however it occurs more frequently in menopause (> 50) and in postmenopause (> 70). The most cancer frequent affects symptoms patients are at every bleeding age, and however vaginal it occurs discharge. more When frequently hematometra in or menopause pyometra (> 50) is and present m the patient postmenopausemay feel ination pain. or by some histological cases endometrial examination of a adenocarcinoma uterus is surgically asymptomatic removed for and the other diagnosis indications. is casually these made cases the during most ultrasound frequent examfindtrialings are thickness polyps are and usually abnormally limited to a small area thickness and of the surrounded endometrial by atrophic mucosa. mucosa. Higher postmenopause incidence polyps rates and of abnormal endometrial endomecancer trial were correlated with polyps estrogen and an inreased or number non-estrogen of serous associated Patients in identified postmenopause in the > 65-age affected group. Endome-trial carcinoma may be estrogen correlated or non-estrogen associated. Patients in postmenopause are often affected by non-estro-gen correlated endometrial carcinoma. According to Kurman and the other authors the first type of endometrial adenocarcinoma(estro-gen correlated) is characterized by low-grade malignancy. On the contrary, non-estrogen correlated neoplasia is more aggressive. In our case series including 102 women >70 years with endometrial carcinoma we found that survival was correlated with stage and grading – early stages were the most frequent and the grade increased with stage. In fact all the patients with relapses had grade 2 or 3 adenocarcinomas. Thirty-one patients > 70 years(30.69%) had a non-endometrioid type of cancer.